During the past decade, Nikolaevskaya Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nikolaevskaya Hospital" #1 collaborator was "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nikolaevskaya Hospital" are "Alzheimer's Disease" (2 trials), "Anemia" (1 trials), "Behavioral Variant Frontotemporal Dementia" (1 trials), "Chronic Kidney Disease" (1 trials) and "End Stage Renal Failure on Dialysis" (1 trials). Many other conditions were trialed in "Nikolaevskaya Hospital" in a lesser frequency.

Most popular intervention types in "Nikolaevskaya Hospital" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alemtuzumab" (1 trials), "Darbepoetin alfa" (1 trials), "Interferon beta-1a" (1 trials), "LMTM" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nikolaevskaya Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Nikolaevskaya Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nikolaevskaya Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nikolaevskaya Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".